Member access

4-Traders Homepage  >  Shares  >  Nasdaq  >  Anacor Pharmaceuticals Inc    ANAC   US0324201013

 SummaryQuotesChart AnalysisNewsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
11/17/2014 11/18/2014 11/19/2014 11/20/2014 11/21/2014 Date
31.15(c) 30.94(c) 30.33(c) 32.08(c) 32.23(c) Last
272 500 285 009 454 928 446 841 549 872 Volume
+0.48% -0.67% -1.97% +5.77% +0.47% Change
More quotes
Company
Anacor Pharmaceuticals, Inc. is a biopharmaceutical company, which focuses on discovering, developing and commercializing novel small-molecule therapeutics derived from its boron chemistry platform.The company has discovered seven compounds that are currently in development including its lead... 
Surperformance© rating of Anacor Pharmaceuticals Inc
Trading Rating : Investor Rating :
More about the company
Chart ANACOR PHARMACEUTICALS INC
Duration : Period :
Anacor Pharmaceuticals Inc Technical Analysis Chart | ANAC | US0324201013 | 4-Traders
Full-screen chart
Financials ($)
Sales 2014 16,2 M
EBIT 2014 -96,0 M
Net income 2014 -98,4 M
Debt 2014 -
Yield 2014 -
Sales 2015 34,6 M
EBIT 2015 -80,3 M
Net income 2015 -75,4 M
Debt 2015 -
Yield 2015 -
PER 2014 -
PER 2015
Capi. / Sales 2014 84,8x
Capi. / Sales 2015 39,8x
Capitalization 1 376 M
More Financials
Latest news on ANACOR PHARMACEUTICALS INC
11/13 ANACOR PHARMACEUTICALS : to Take Part in the 2014 Credit Suisse Healthcare Confe..
11/12 ANACOR PHARMACEUTICALS : Reports Third Quarter 2014 Financial Results
11/11 ANACOR PHARMACEUTICALS : Posts 3rd Quarter 2014 Financial Results
11/07 ANACOR PHARMACEUTICALS : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDI..
11/07 ANACOR PHARMACEUTICALS : to Present at the 2014 Credit Suisse Healthcare Confere..
11/06 ANACOR PHARMACEUTICALS : posts 3Q loss
11/06 ANACOR PHARMACEUTICALS : Results of Operations and Financial Condition, Financia..
11/06 ANACOR PHARMACEUTICALS : Reports Third Quarter 2014 Financial Results
11/03ANACOR PHARMACEUTICALS INC : quaterly earnings release
10/30 ANACOR PHARMACEUTICALS : Announces Third Quarter 2014 Financial Results Conferen..
10/16 ANACOR PHARMACEUTICALS : Entry into a Material Definitive Agreement, Creation of..
10/15 ANACOR PHARMACEUTICALS : Announces Pricing of Offering of $75 Million of 2.00% C..
More news


Comments 
Advertisement
Technical analysis trends
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Technical analysis
Income Statement Evolution
More Financials
EPS Revisions
More Estimates Revisions
Dynamic quotes  
ON
| OFF